Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Dialysis Corp Of America (DCAI) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data at Dialysis Corp Of America. Table 2 shows the detailed insider transactions. The reporting company's CIK number is 201653.
Total stock buying since 2005: $51,645.
Total stock sales since 2005: $4,128,543.
Total stock option exercises since 2005: $766,489.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2009 | 6,700 | $29,961 | 2,000 | $10,400 | 7,834 | $31,491 |
| 2008 | 3,000 | $21,684 | 0 | $0 | 0 | $0 |
| 2007 | 0 | $0 | 12,000 | $121,573 | 0 | $0 |
| 2006 | 0 | $0 | 48,376 | $634,368 | 262,500 | $734,998 |
| 2005 | 0 | $0 | 251,624 | $3,362,202 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2009-06 | 0 | $0 | 2,000 | $10,400 | 7,834 | $31,491 |
| 2009-05 | 6,700 | $29,961 | 0 | $0 | 0 | $0 |
| 2008-06 | 3,000 | $21,684 | 0 | $0 | 0 | $0 |
| 2007-10 | 0 | $0 | 10,000 | $93,835 | 0 | $0 |
| 2007-01 | 0 | $0 | 2,000 | $27,738 | 0 | $0 |
| 2006-08 | 0 | $0 | 10,000 | $131,000 | 0 | $0 |
| 2006-03 | 0 | $0 | 38,376 | $503,368 | 262,500 | $734,998 |
| 2005-11 | 0 | $0 | 251,624 | $3,362,202 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2009-06-08 | Bienenstock Alexander (Director) | Option Ex | 1,417 | 4.02 | 5,696 |
| 2009-06-08 | Trause Robert W (Director) | Option Ex | 1,417 | 4.02 | 5,696 |
| 2009-06-08 | Fischbein Peter D (Director) | Option Ex | 5,000 | 4.02 | 20,099 |
| 2009-06-01 | Bienenstock Alexander (Director) | Sale | 2,000 | 5.20 | 10,400 |
| 2009-05-29 | Zimmerman Joanne (VP, Clinical Services) | Buy | 1,000 | 4.60 | 4,600 |
| 2009-05-15 | Carey Thomas Patrick (VP, Operations) | Buy | 3,500 | 4.42 | 15,470 |
| 2009-05-15 | Everett Stephen W (President & CEO) | Buy | 1,500 | 4.55 | 6,825 |
| 2009-05-14 | Zimmerman Joanne (VP, Clinical Services) | Buy | 700 | 4.38 | 3,066 |
| 2008-06-24 | Carey Thomas Patrick (Vice President, Operations) | Buy | 1,500 | 7.22 | 10,830 |
| 2008-06-10 | Jeanneret Andrew J (VP Finance, CFO) | Buy | 700 | 7.30 | 5,110 |
| 2008-06-09 | Jeanneret Andrew J (VP Finance, CFO) | Buy | 800 | 7.18 | 5,744 |
| 2007-10-08 | Bienenstock Alexander (Director) | Sale | 6,295 | 9.23 | 58,102 |
| 2007-10-02 | Bienenstock Alexander (Director) | Sale | 1,705 | 9.58 | 16,333 |
| 2007-10-01 | Bienenstock Alexander (Director) | Sale | 2,000 | 9.70 | 19,400 |
| 2007-01-12 | Langbein Thomas K (Director) | Sale | 1,900 | 13.87 | 26,353 |
| 2007-01-09 | Langbein Thomas K (Director) | Sale | 100 | 13.85 | 1,385 |
| 2006-08-16 | Bienenstock Alexander (Director) | Sale | 10,000 | 13.10 | 131,000 |
| 2006-03-29 | Rowe Michael (Vice President, Operations) | Option Ex | 175,000 | 2.19 | 383,250 |
| 2006-03-22 | Everett Stephen W (President and CEO) | Sale | 18,376 | 13.51 | 248,259 |
| 2006-03-13 | Fischbein Peter D (Director) | Sale | 8,806 | 12.75 | 112,276 |
| 2006-03-09 | Fischbein Peter D (Director) | Sale | 200 | 12.75 | 2,550 |
| 2006-03-08 | Fischbein Peter D (Director) | Sale | 10,994 | 12.76 | 140,283 |
| 2006-03-07 | Everett Stephen W (President and CEO) | Option Ex | 37,500 | 4.02 | 150,749 |
| 2006-03-07 | Langbein Thomas K (Director) | Option Ex | 50,000 | 4.02 | 200,999 |
| 2005-11-23 | Everett Stephen W (President and CEO) | Sale | 81,624 | 13.69 | 1,117,432 |
| 2005-11-23 | Langbein Thomas K (Director) | Sale | 70,000 | 13.81 | 967,050 |
| 2005-11-18 | Langbein Thomas K (Director) | Sale | 40,000 | 12.68 | 507,200 |
| 2005-11-15 | Langbein Thomas K (Director) | Sale | 60,000 | 12.84 | 770,520 |
Insider trading activities including stock purchases, stock sales, and option exercises of DCAI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Dialysis Corp Of America (symbol DCAI, CIK number 201653) see the Securities and Exchange Commission (SEC) website.